CITIC Securities Company Limited增持国药控股(01099)23.12万股每股作价约21.66港元

智通财经

2024-12-30

智通财经APP获悉，据香港联交所最新数据显示，12月23日，CITIC Securities Company Limited增持国药控股(01099)23.12万股，每股作价21.6569港元，总金额约为500.71万港元。增持后最新持股数目约为1.21亿股，最新持股比例为9%。

补充资料：权益为中信证券资产管理有限公司代其管理的全部资产管理计划披露持有的国药控股股份有限公司 - H股权益。

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2495510588"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2495510588\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2495510588?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2024-12-30 19:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2495510588","market":"hk","top_or_hot":-1,"title":"CITIC Securities Company Limited增持国药控股(01099)23.12万股 每股作价约21.66港元","media":"智通财经","content":"<html><body><p>智通财经APP获悉，据香港联交所最新数据显示，12月23日，CITIC Securities Company Limited增持<a href=\"https://laohu8.com/S/01099\">国药控股</a>(01099)23.12万股，每股作价21.6569港元，总金额约为500.71万港元。增持后最新持股数目约为1.21亿股，最新持股比例为9%。</p><p>补充资料：权益为<a href=\"https://laohu8.com/S/600030\">中信证券</a>资产管理有限公司代其管理的全部资产管理计划披露持有的国药控股股份有限公司 - H股权益。</p><p><img src=\"https://img.zhitongcaijing.com/image/20241230/1735556695432061.png\"/></p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>CITIC Securities Company Limited增持国药控股(01099)23.12万股 每股作价约21.66港元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCITIC Securities Company Limited增持国药控股(01099)23.12万股 每股作价约21.66港元\n</h2>\n<h4 class=\"meta\">\n\n\n2024-12-30 19:04 北京时间   <a href=\"http://www.zhitongcaijing.com/content/detail/1231057.html\"><strong>智通财经</strong></a>\n</h4>\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，据香港联交所最新数据显示，12月23日，CITIC Securities Company Limited增持国药控股(01099)23.12万股，每股作价21.6569港元，总金额约为500.71万港元。增持后最新持股数目约为1.21亿股，最新持股比例为9%。补充资料：权益为中信证券资产管理有限公司代其管理的全部资产管理计划披露持有的国药控股股份有限公司 - H股权益。</p>\n<a href=\"http://www.zhitongcaijing.com/content/detail/1231057.html\">网页链接</a>\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1197","symbol_name":"保健护理产品经销商","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1231057.html","article_id":"2495510588","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2495510588","pubTimestamp":1735556675,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP获悉，据香港联交所最新数据显示，12月23日，CITIC Securities Company Limited增持国药控股(01099)23.12万股，每股作价21.6569港元，总金额约为500.71万港元。增持后最新持股数目约为1.21亿股，最新持股比例为9%。补充资料：权益为中信证券资产管理有限公司代其管理的全部资产管理计划披露持有的国药控股股份有限公司 - H股权益。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1197":"保健护理产品经销商","01099":"国药控股","BK1515":"抗疫概念","LU0640798160.USD":"EASTSPRING INVESTMENTS GLOBAL EMERGING MARKET DYNAMIC \"A\" (USD) ACC","BK1500":"做空集合股","LU1115378108.SGD":"Eastspring Investments - Global Emerging Markets Dynamic AS SGD"},"translate_title":"CITIC Securities Company Limited increased its holdings of 231,200 shares of Sinopharm Holdings (01099) at a price of approximately HK $21.66 per share","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01099":1},"content_text":"智通财经APP获悉，据香港联交所最新数据显示，12月23日，CITIC Securities Company Limited增持国药控股(01099)23.12万股，每股作价21.6569港元，总金额约为500.71万港元。增持后最新持股数目约为1.21亿股，最新持股比例为9%。补充资料：权益为中信证券资产管理有限公司代其管理的全部资产管理计划披露持有的国药控股股份有限公司 - H股权益。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0}}}